vs
Side-by-side financial comparison of COMMERCE BANCSHARES INC (CBSH) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $475.7M, roughly 1.0× COMMERCE BANCSHARES INC). COMMERCE BANCSHARES INC runs the higher net margin — 29.8% vs 6.8%, a 23.0% gap on every dollar of revenue. On growth, COMMERCE BANCSHARES INC posted the faster year-over-year revenue change (11.1% vs -1.7%). Over the past eight quarters, COMMERCE BANCSHARES INC's revenue compounded faster (7.1% CAGR vs -0.1%).
Commerce Bancshares, Inc. is a regional bank holding company headquartered in Missouri, with principal offices in Kansas City and St. Louis. It is the corporate parent of Commerce Bank, which offers a diversified line of financial services, including business and personal banking, wealth management and investments through its affiliated companies.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
CBSH vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $475.7M | $493.8M |
| Net Profit | $141.6M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 29.8% | 6.8% |
| Revenue YoY | 11.1% | -1.7% |
| Net Profit YoY | 10.5% | 10.5% |
| EPS (diluted) | $0.96 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $475.7M | — | ||
| Q4 25 | $449.4M | $493.8M | ||
| Q3 25 | $441.0M | $492.9M | ||
| Q2 25 | $445.8M | $468.8M | ||
| Q1 25 | $428.1M | $458.4M | ||
| Q4 24 | $422.1M | $502.4M | ||
| Q3 24 | $421.4M | $511.2M | ||
| Q2 24 | $414.5M | $504.3M |
| Q1 26 | $141.6M | — | ||
| Q4 25 | $140.7M | $33.7M | ||
| Q3 25 | $141.5M | $71.7M | ||
| Q2 25 | $152.5M | $39.3M | ||
| Q1 25 | $131.6M | $20.7M | ||
| Q4 24 | $136.1M | $30.5M | ||
| Q3 24 | $138.0M | $19.4M | ||
| Q2 24 | $139.6M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | 40.8% | 9.9% | ||
| Q3 25 | 41.9% | 13.8% | ||
| Q2 25 | 44.0% | 12.8% | ||
| Q1 25 | 39.2% | 7.0% | ||
| Q4 24 | 41.2% | 7.8% | ||
| Q3 24 | 42.4% | 6.6% | ||
| Q2 24 | 43.4% | -31.3% |
| Q1 26 | 29.8% | — | ||
| Q4 25 | 31.3% | 6.8% | ||
| Q3 25 | 32.1% | 14.5% | ||
| Q2 25 | 34.2% | 8.4% | ||
| Q1 25 | 30.7% | 4.5% | ||
| Q4 24 | 32.2% | 6.1% | ||
| Q3 24 | 32.8% | 3.8% | ||
| Q2 24 | 33.7% | -30.3% |
| Q1 26 | $0.96 | — | ||
| Q4 25 | $0.86 | $0.40 | ||
| Q3 25 | $1.06 | $0.84 | ||
| Q2 25 | $1.14 | $0.46 | ||
| Q1 25 | $0.98 | $0.24 | ||
| Q4 24 | $0.83 | $0.37 | ||
| Q3 24 | $1.01 | $0.23 | ||
| Q2 24 | $1.03 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $4.3B | $865.9M |
| Total Assets | $35.7B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $3.8B | $865.9M | ||
| Q3 25 | $3.8B | $890.7M | ||
| Q2 25 | $3.6B | $833.8M | ||
| Q1 25 | $3.5B | $789.2M | ||
| Q4 24 | $3.3B | $764.9M | ||
| Q3 24 | $3.4B | $732.5M | ||
| Q2 24 | $3.1B | $706.5M |
| Q1 26 | $35.7B | — | ||
| Q4 25 | $32.9B | $2.2B | ||
| Q3 25 | $32.3B | $2.2B | ||
| Q2 25 | $32.3B | $2.1B | ||
| Q1 25 | $32.4B | $2.0B | ||
| Q4 24 | $32.0B | $2.2B | ||
| Q3 24 | $31.5B | $2.1B | ||
| Q2 24 | $30.6B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $645.1M | $114.1M | ||
| Q3 25 | $129.0M | $137.3M | ||
| Q2 25 | $111.2M | $137.2M | ||
| Q1 25 | $138.6M | $-117.5M | ||
| Q4 24 | $577.9M | $133.0M | ||
| Q3 24 | $431.7M | $91.8M | ||
| Q2 24 | $147.4M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $592.4M | — | ||
| Q3 25 | $113.3M | — | ||
| Q2 25 | $100.5M | — | ||
| Q1 25 | $126.0M | — | ||
| Q4 24 | $531.7M | — | ||
| Q3 24 | $419.1M | — | ||
| Q2 24 | $138.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | 131.8% | — | ||
| Q3 25 | 25.7% | — | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | 29.4% | — | ||
| Q4 24 | 126.0% | — | ||
| Q3 24 | 99.5% | — | ||
| Q2 24 | 33.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.59× | 3.39× | ||
| Q3 25 | 0.91× | 1.91× | ||
| Q2 25 | 0.73× | 3.49× | ||
| Q1 25 | 1.05× | -5.66× | ||
| Q4 24 | 4.25× | 4.36× | ||
| Q3 24 | 3.13× | 4.72× | ||
| Q2 24 | 1.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBSH
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
